Hikma Pharmaceuticals (HIK)

Sector:

Pharma and Biotech

Index:

FTSE 100

2,068.00p
   
  • Change Today:
    -2.00p
  • 52 Week High: 2,340.00
  • 52 Week Low: 1,772.00
  • Currency: UK Pounds
  • Shares Issued: 234.72m
  • Volume: 420,895
  • Market Cap: £4,854.00m
  • RiskGrade: 125
  • Beta: 0.01

HIK Overview

Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The company sells 113 branded and non-branded generic pharmaceutical products in 34 countries worldwide. The majority of Hikma’s operations are in the United States, the Middle East and North Africa Region and Europe.

1 Day Chart (19-05-2025)

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 2.9% 0.0%
Div Cover 2.8 2.8
Op Mrgn 19.6% 22.3%
ROCE 24.3%  
Latest F'cast
P/E 12.3 11.9
PEG 27.5 3.9
Pr/Revenue 2.1 1.5
Pr/Book 2.8  
Latest F'cast
Revenue 8.8% -20.9%
PBT 61.9% 21.0%
EPS 0.4% 3.1%
DPS 11.1% -41.6%

HIK Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 2,341.00 558.00 172.90¢ 19.5 1.3 +15% 50.00¢ 1.5%
31-Dec-21 2,553.00 544.00 194.80¢ 15.2 1.2 +13% 54.00¢ 1.8%
31-Dec-22 2,517.00 233.00 181.00¢ 11.5 n/a -7% 56.00¢ 2.7%
31-Dec-23 2,875.00 281.00 223.00¢ 10.7 0.5 +23% 72.00¢ 3.0%
31-Dec-24 3,127.00 455.00 224.00¢ 11.9 n/a 0% 80.00¢ 3.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

HIK Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 3,305.88 735.79 173.59p 11.9 3.9 +3% 62.49p 0.0%
31-Dec-26 3,453.86 787.49 188.92p 10.9 1.2 +9% 66.92p 0.0%
31-Dec-27 3,626.89 845.83 206.53p 10.0 1.1 +9% 72.81p 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

HIK Company Announcements

Medium-term Group guidance ahead of US site visit 15-May-2025 12:00 RNS
Director/PDMR Shareholding 08-May-2025 16:35 RNS
S&P upgrades Hikma to ‘BBB’ 08-May-2025 10:48 RNS

HIK ShareCast News

Hikma surges as investors welcome medium-term gu... 15-May-2025 ShareCast
London close: Burberry surges on mixed day for s... 14-May-2025 ShareCast
London close: Stocks rally on US-China tariff deal 12-May-2025 ShareCast

HIK Top Newspaper Links

Hikma boosts injectables business with $300m deal 29-May-2014 Telegraph
MARKET REPORT: Shares jump as Hikma Pharmaceutic... 08-May-2014 Daily Mail
Hikma prepares return to Libya 26-Aug-2011 The Independent

Latest HIK Director Deals

Traded Action Notifier PriceAmountValue
06-May-25 Buy Riad Mishlawi 2,023.00p 1,454 £29,414.42
08-Apr-25 Sell Victoria Hull 1,800.00p 2,777 £49,986.00
28-Feb-25 Transfer From Mazen Darwazah 0.000p 14,844 £0.00

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

HIK Market Data

Currency UK Pounds
Share Price 2,068.00p
Change Today -2.00p
% Change -0.10 %
52 Week High 2,340.00
52 Week Low 1,772.00
Volume 420,895
Shares Issued 234.72m
Market Cap £4,854.00m
Beta 0.01
RiskGrade 125

HIK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
90.08% below the market average90.08% below the market average90.08% below the market average90.08% below the market average90.08% below the market average
48.94% below the sector average48.94% below the sector average48.94% below the sector average48.94% below the sector average48.94% below the sector average
Price Trend
62.78% above the market average62.78% above the market average62.78% above the market average62.78% above the market average62.78% above the market average
65.96% above the sector average65.96% above the sector average65.96% above the sector average65.96% above the sector average65.96% above the sector average
Income
8.20% above the market average8.20% above the market average8.20% above the market average8.20% above the market average8.20% above the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average
Growth
29.11% above the market average29.11% above the market average29.11% above the market average29.11% above the market average29.11% above the market average
29.03% above the sector average29.03% above the sector average29.03% above the sector average29.03% above the sector average29.03% above the sector average

What The Brokers Say

Strong Buy 6
Buy 3
Neutral 3
Sell 0
Strong Sell 0
Total 12
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

HIK Dividends

  Latest Previous
  Final Interim
Ex-Div 20-Mar-25 15-Aug-24
Paid 01-May-25 20-Sep-24
Amount 48.00¢ 32.00¢

Trades for 19-May-2025

Time Volume / Share Price
15:37 0 @ 2,064.00p
15:35 0 @ 2,064.00p
15:35 0 @ 2,064.00p
16:39 1 @ 2,068.00p
16:37 16,836 @ 2,066.24p

HIK Key Personnel

CEO Riad Mishlawi

Top of Page